JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
Other Long-Term Assets
JW (Cayman) Therapeutics Co Ltd
Other Long-Term Assets Peer Comparison
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Other Long-Term Assets
¥10.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Other Long-Term Assets
¥304.3m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Other Long-Term Assets
¥283.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Other Long-Term Assets
¥405.6m
|
CAGR 3-Years
39%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Other Long-Term Assets
¥960.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
34%
|
CAGR 10-Years
34%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Other Long-Term Assets
¥75.6m
|
CAGR 3-Years
68%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
10.9m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Other Long-Term Assets amounts to 10.9m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
48%
Over the last year, the Other Long-Term Assets growth was 0%.